Format

Send to

Choose Destination
Mol Cell Endocrinol. 2016 Feb 5;421:28-33. doi: 10.1016/j.mce.2015.05.031. Epub 2015 May 29.

Xenograft models for adrenocortical carcinoma.

Author information

1
Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, Munich, Germany. Electronic address: Constanze.Hantel@med.uni-muenchen.de.
2
Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, Munich, Germany.

Abstract

Adrenocortical carcinomas (ACCs) are rare, heterogeneous and very malignant endocrine tumors with a poor prognosis. An important prerequisite to optimize existing therapeutic regimens and to develop novel therapeutic strategies are preclinical disease models. In recent years molecular and genetic profiling of surgical tumor specimen led to the identification of novel interesting markers. However, precise involvement of these markers in tumorigenesis and their functional relevance in therapeutic outcome is still under investigation. Xenograft models are important tools for such functional studies as they bear the potential to mimic the complexity of solid tumors including tumor cells, stroma and blood vessels. Thus, for the successful and safe development of novel therapeutic strategies xenograft models remain to be indispensable experimental tools. Here we provide an overview on currently existing xenograft models for ACC, their tissue origins, establishment, implications as well as limitations.

KEYWORDS:

Adrenocortical carcinoma; Preclinical animal model; Xenograft

PMID:
26033247
DOI:
10.1016/j.mce.2015.05.031
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center